dc.contributor.author | ROTARU, Ludmila | |
dc.contributor.author | SIDORENKO, Ludmila | |
dc.date.accessioned | 2024-04-26T06:31:42Z | |
dc.date.available | 2024-04-26T06:31:42Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | ROTARU, Ludmila, SIDORENKO, Ludmila. The approach of molecular medicine to the treatment of Gaucher disease. In: Quo Vadis – Ethics of the Scientific Research: conf. NANO-2024, event devoted to the 60th anniversary of the Technical University of Moldova, 15-18 April 2024, Chişinău, Republica Moldova: Program and proceedings of the conference, Chişinău 2024, pp. 103-104. ISBN 978-9975-64-422-8. | en_US |
dc.identifier.isbn | 978-9975-64-422-8 | |
dc.identifier.uri | http://repository.utm.md/handle/5014/26934 | |
dc.description.abstract | This review study provides the most recent information on the therapies approved for the treatment of the disease. Material and methods. Narrative synthesis of specialized literature in databases: PubMed, Gene Cards, National Library of medicine, Google Scholar and Hinari of the years 2014 to 2024 were analyzed. Results. Enzyme replacement therapy is an effective tool in the treatment of Type 1 Gaucher disease. Treatment is done via infusion of imiglucerase. This is a synthetic substance called glucocerebrosidase. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Technical University of Moldova | en_US |
dc.relation.ispartofseries | NANO-2024 "Quo Vadis – Ethics of the Scientific Research", event devoted to the 60th anniversary of the Technical University of Moldova;15-18 April 2024, Chişinău, Republica Moldova | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.subject | Gaucher disease | en_US |
dc.subject | enzyme replacement therapy | en_US |
dc.title | The approach of molecular medicine to the treatment of Gaucher disease | en_US |
dc.type | Article | en_US |
The following license files are associated with this item: